Original
Eficiencia de la administración mensual subcutánea de metoxi-polietilenglicol epoetina β (Mircera®) en pacientes estables en hemodiálisis previamente tratados con eritropoyetinaEficiencia de la administración sc mensual de MIRCERA en pacientes en HD
Efficiency of monthly subcutaneous administration of methoxy-polyethylene glycol-epoetin beta (Mircera) in stable patients under hemodialysis previously treated with erythropoietin
María Dolores Albero Molina
, Ramón López-Menchero Martínez, Carlos del Pozo Fernández, Luis Álvarez Fernández, Laura Sánchez Rodríguez
Autor para correspondencia
Sección de Nefrología, Hospital Virgen de los Lirios, Alcoy, Alicante, España
Leído
6913
Vecesse ha leído el artículo
1313
Total PDF
5600
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 13 | 7 | 20 |
| 2025 11 | 50 | 21 | 71 |
| 2025 10 | 47 | 23 | 70 |
| 2025 9 | 38 | 16 | 54 |
| 2025 8 | 48 | 16 | 64 |
| 2025 7 | 34 | 10 | 44 |
| 2025 6 | 35 | 9 | 44 |
| 2025 5 | 36 | 5 | 41 |
| 2025 4 | 52 | 3 | 55 |
| 2025 3 | 52 | 6 | 58 |
| 2025 2 | 35 | 7 | 42 |
| 2025 1 | 34 | 4 | 38 |
| 2024 12 | 29 | 2 | 31 |
| 2024 11 | 20 | 2 | 22 |
| 2024 10 | 24 | 6 | 30 |
| 2024 9 | 54 | 4 | 58 |
| 2024 8 | 54 | 5 | 59 |
| 2024 7 | 35 | 8 | 43 |
| 2024 6 | 41 | 4 | 45 |
| 2024 5 | 64 | 3 | 67 |
| 2024 4 | 45 | 4 | 49 |
| 2024 3 | 50 | 6 | 56 |
| 2024 2 | 47 | 5 | 52 |
| 2024 1 | 61 | 9 | 70 |
| 2023 12 | 46 | 11 | 57 |
| 2023 11 | 55 | 5 | 60 |
| 2023 10 | 90 | 7 | 97 |
| 2023 9 | 51 | 6 | 57 |
| 2023 8 | 46 | 9 | 55 |
| 2023 7 | 82 | 10 | 92 |
| 2023 6 | 64 | 7 | 71 |
| 2023 5 | 106 | 14 | 120 |
| 2023 4 | 88 | 2 | 90 |
| 2023 3 | 77 | 2 | 79 |
| 2023 2 | 71 | 9 | 80 |
| 2022 1 | 73 | 9 | 82 |
| 2022 12 | 38 | 5 | 43 |
| 2022 11 | 73 | 8 | 81 |
| 2022 10 | 52 | 7 | 59 |
| 2022 9 | 43 | 13 | 56 |
| 2022 8 | 43 | 7 | 50 |
| 2022 7 | 42 | 13 | 55 |
| 2022 6 | 23 | 20 | 43 |
| 2022 5 | 38 | 11 | 49 |
| 2022 4 | 33 | 13 | 46 |
| 2022 3 | 42 | 13 | 55 |
| 2022 2 | 57 | 8 | 65 |
| 2021 1 | 77 | 15 | 92 |
| 2021 12 | 59 | 17 | 76 |
| 2021 11 | 61 | 11 | 72 |
| 2021 10 | 55 | 13 | 68 |
| 2021 9 | 40 | 7 | 47 |
| 2021 8 | 33 | 5 | 38 |
| 2021 7 | 36 | 12 | 48 |
| 2021 6 | 32 | 15 | 47 |
| 2021 5 | 32 | 8 | 40 |
| 2021 4 | 140 | 27 | 167 |
| 2021 3 | 52 | 18 | 70 |
| 2021 2 | 48 | 14 | 62 |
| 2020 1 | 43 | 19 | 62 |
| 2020 12 | 37 | 17 | 54 |
| 2020 11 | 57 | 7 | 64 |
| 2020 10 | 30 | 13 | 43 |
| 2020 9 | 21 | 12 | 33 |
| 2020 8 | 27 | 15 | 42 |
| 2020 7 | 28 | 10 | 38 |
| 2020 6 | 70 | 13 | 83 |
| 2020 5 | 33 | 9 | 42 |
| 2020 4 | 37 | 10 | 47 |
| 2020 3 | 61 | 17 | 78 |
| 2020 2 | 68 | 15 | 83 |
| 2020 1 | 63 | 11 | 74 |
| 2019 12 | 54 | 16 | 70 |
| 2019 11 | 68 | 13 | 81 |
| 2019 10 | 50 | 5 | 55 |
| 2019 9 | 57 | 9 | 66 |
| 2019 8 | 20 | 6 | 26 |
| 2019 7 | 31 | 23 | 54 |
| 2019 6 | 99 | 45 | 144 |
| 2019 5 | 214 | 79 | 293 |
| 2019 4 | 120 | 43 | 163 |
| 2019 3 | 41 | 7 | 48 |
| 2019 2 | 48 | 6 | 54 |
| 2019 1 | 37 | 10 | 47 |
| 2018 12 | 46 | 6 | 52 |
| 2018 11 | 45 | 7 | 52 |
| 2018 10 | 54 | 18 | 72 |
| 2018 9 | 24 | 7 | 31 |
| 2018 8 | 46 | 8 | 54 |
| 2018 7 | 28 | 4 | 32 |
| 2018 6 | 15 | 10 | 25 |
| 2018 5 | 18 | 13 | 31 |
| 2018 4 | 59 | 5 | 64 |
| 2018 3 | 44 | 2 | 46 |
| 2018 2 | 23 | 3 | 26 |
| 2018 1 | 20 | 0 | 20 |
| 2017 12 | 39 | 1 | 40 |
| 2017 11 | 9 | 2 | 11 |
| 2017 10 | 16 | 3 | 19 |
| 2017 9 | 15 | 6 | 21 |
| 2017 8 | 22 | 11 | 33 |
| 2017 7 | 13 | 6 | 19 |
| 2017 6 | 30 | 15 | 45 |
| 2017 5 | 19 | 14 | 33 |
| 2017 4 | 17 | 6 | 23 |
| 2017 3 | 36 | 24 | 60 |
| 2017 2 | 21 | 3 | 24 |
| 2016 1 | 28 | 2 | 30 |
| 2016 12 | 26 | 4 | 30 |
| 2016 11 | 50 | 5 | 55 |
| 2016 10 | 60 | 7 | 67 |
| 2016 9 | 53 | 6 | 59 |
| 2016 8 | 41 | 3 | 44 |
| 2016 7 | 29 | 1 | 30 |
| 2016 6 | 25 | 15 | 40 |
| 2016 5 | 24 | 16 | 40 |
| 2016 4 | 30 | 13 | 43 |
| 2016 3 | 24 | 14 | 38 |
| 2016 2 | 16 | 7 | 23 |
| 2015 1 | 29 | 11 | 40 |
| 2015 12 | 22 | 10 | 32 |
| 2015 11 | 13 | 10 | 23 |
| 2015 10 | 20 | 8 | 28 |
| 2015 9 | 16 | 6 | 22 |
| 2015 8 | 13 | 7 | 20 |
| 2015 7 | 12 | 7 | 19 |
| 2014 1 | 0 | 1 | 1 |
Mostrar todo